Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor + warfarin versus clopidogrel + aspirin + warfarin after PCI in atrial fibrillation
ChiCTR-TRC-14004992Phase 4Recruiting
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Aug 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ticagrelor, warfarin, clopidogrel and aspirin in Atrial fibrillation (AFib) and coronary arteriosclerosis (2 arms), sponsored by Zhongda Hospital, Southeast University. Primary endpoint: Overall bleeding. Started Aug 2014; status: recruiting.
02
Drugs
ticagrelorwarfarinclopidogrelaspirin
03
Conditions
Atrial fibrillation (AFib)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-14004992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004992.